Taiwan FDA registration b8ac7e4d327a4fec7f0084dbe52adb56
"Neo-branched" human T-lymphotropic virus antibody Western ink dot method 2.4 reagent
TW: “新科化” 人類嗜T淋巴球病毒抗體西方墨點法2.4試劑
Taiwan·Risk Class 3·MP BIOMEDICALS ASIA PACIFIC PTE. LTD.·Registered Aug 16, 2012 – Jun 04, 2014CancelledRegistration details
- Analysis ID
- b8ac7e4d327a4fec7f0084dbe52adb56
- Customs Code
- DHA00602384808
Company information
- Manufacturer
- MP BIOMEDICALS ASIA PACIFIC PTE. LTD.
- Manufacturer Country
- Singapore
- Authorized Representative
- NEW SCIENTIFIC EQUIPMENT CO., LTD.
Product details
- Intended Use
- Western ink spots are legally tested for T-lymphotropic virus type 1 and type 2 antibodies in human serum or plasma, and are used for confirmation.
- Product Type (Level 1)
- B Hematology, pathology, and genetics
- Product Type (Level 2)
- B.4020 Analysis of specific tests
- Import Information
- import
Dates and status
- Registration Date
- Aug 16, 2012
- Expiry Date
- Jun 04, 2014
- Cancellation Date
- May 25, 2018
Cancellation information
- Status
- Logged out
- Reason
- 許可證已逾有效期
About this record
Access comprehensive regulatory information for "Neo-branched" human T-lymphotropic virus antibody Western ink dot method 2.4 reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number b8ac7e4d327a4fec7f0084dbe52adb56 and manufactured by MP BIOMEDICALS ASIA PACIFIC PTE. LTD.. The authorized representative in Taiwan is NEW SCIENTIFIC EQUIPMENT CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices